Peripheral T-cell lymphoma emerging in a patient with aggressive polymyositis: molecular evidence for neoplastic transformation of an oligoclonal T-cell infiltrate

被引:3
|
作者
Tsankova, Nadejda M. [1 ,2 ]
Bevan, Carolyn [2 ,3 ]
Jobanputra, Vaidehi [2 ,4 ]
Ko, Yen Chen Kevin [2 ,4 ]
Mayer, Elizabeth W. [2 ,5 ]
Lefkowitch, Jay H. [2 ,4 ]
Mansukhani, Mahesh [2 ,4 ]
Rowland, Lewis P. [2 ,3 ]
Bhagat, Govind [2 ,6 ]
Tanji, Kurenai [1 ,2 ,3 ]
机构
[1] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, Div Neuropathol, New York, NY 10032 USA
[2] New York Presbyterian Hosp, New York, NY 10032 USA
[3] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA
[4] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA
[5] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA
[6] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, Div Hematopathol, New York, NY 10032 USA
关键词
Polymyositis; T-cell lymphoma; Oligoclonal; Inflammatory myopathy; SNP-array; TCR next-generation sequencing; EPSTEIN-BARR-VIRUS; RECEPTOR REPERTOIRE; DERMATOMYOSITIS; MUSCLE; LYMPHOCYTES; MYOPATHY; THERAPY;
D O I
10.1007/s00401-013-1164-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report a rare case of peripheral T-cell lymphoma arising in a 52-year-old man with biopsy-proven aggressive polymyositis, who had cardiac involvement, progressive bulbar symptoms, and died 11 months post diagnosis due to multiorgan failure. Using a multimodality approach including immunohistochemistry, genome-wide single nucleotide polymorphism (SNP)-array analysis, and high-throughput sequencing of the complementary determining region 3 (CDR3) of T-cell receptor beta (TCR beta) genes, our study demonstrates a molecular link between polymyositis and T-cell lymphoma, and provides evidence of the rapid and possibly late occurrence of genomic instability during neoplastic transformation of an oligoclonal T-cell population. Immunohistochemical analysis revealed loss of CD5, CD7, and CD8 antigen expression in autopsy tissue samples, as well as the occurrence of aberrant CD56 expression, not seen in pre-mortem biopsies, supporting the emergence of a neoplastic T-cell population. Multiplex polymerase chain reaction and next-generation sequencing of the TCR beta CDR3 region displayed two unique T-cell clones in both the diagnostic biopsy confirming polymyositis and the autopsy muscle tissue exhibiting T-cell lymphoma, linking the two pathological processes. SNP-array analysis revealed complex genomic abnormalities at autopsy but not in the pre-mortem muscle biopsies displaying polymyositis, confirming malignant transformation of the oligoclonal T-cell infiltrate. Our findings raise the possibility that clinically aggressive polymyositis might represent a preneoplastic condition in some instances, similar to certain other autoimmune and inflammatory disorders.
引用
收藏
页码:595 / 601
页数:7
相关论文
共 50 条
  • [1] Peripheral T-cell lymphoma emerging in a patient with aggressive polymyositis: molecular evidence for neoplastic transformation of an oligoclonal T-cell infiltrate
    Nadejda M. Tsankova
    Carolyn Bevan
    Vaidehi Jobanputra
    Yen Chen Kevin Ko
    Elizabeth W. Mayer
    Jay H. Lefkowitch
    Mahesh Mansukhani
    Lewis P. Rowland
    Govind Bhagat
    Kurenai Tanji
    Acta Neuropathologica, 2013, 126 : 595 - 601
  • [2] T-cell therapies for T-cell lymphoma
    Toner, Keri
    Bollard, Catherine M.
    Dave, Hema
    CYTOTHERAPY, 2019, 21 (09) : 935 - 942
  • [3] Peripheral T-cell lymphoma
    Foss, Francine M.
    Zinzani, Pier Luigi
    Vose, Julie M.
    Gascoyne, Randy D.
    Rosen, Steven T.
    Tobinai, Kensei
    BLOOD, 2011, 117 (25) : 6756 - 6767
  • [4] Angioimmunoblastic T-cell lymphoma: a rare subtype of peripheral T-cell lymphoma
    Rai, Manoj Ponadka
    Bedi, Prabhjot Singh
    Marinas, Edwin B.
    Khan, Nazia Naz S.
    CLINICAL CASE REPORTS, 2018, 6 (04): : 750 - 752
  • [5] Romidepsin for peripheral T-cell lymphoma
    Khot, Amit
    Dickinson, Michael
    Prince, H. Miles
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (04) : 351 - 359
  • [6] Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma
    Yap, Daniel Ren Yi
    Lim, Jing Quan
    Huang, Dachuan
    Ong, Choon Kiat
    Chan, Jason Yongsheng
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [7] Emerging drugs for T-cell lymphoma
    Dickinson, Michael
    Prince, Henry Miles
    EXPERT OPINION ON EMERGING DRUGS, 2014, 19 (02) : 201 - 213
  • [8] Peripheral T-cell lymphoma of the eyelid
    Mito, Hidenori
    Kakizaki, Hirohiko
    Tsuji, Hideki
    Ide, Atsushi
    Takeuchi, Kengo
    Takamura, Hiroshi
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2006, 50 (04) : 388 - 390
  • [9] T-cell dysfunction in natural killer/T-cell lymphoma
    Feng, Xiaoyan
    Meng, Miaomiao
    Li, Hongwen
    Gao, Yuyang
    Song, Wenting
    Di, Ruiqing
    Li, Zhaoming
    Zhang, Xudong
    Zhang, Mingzhi
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [10] Peripheral NK/T-cell lymphoma
    Ruediger, T.
    Zettl, A.
    Adam, P.
    Bonzheim, I.
    Geissinger, E.
    Mueller-Hermelink, H. K.
    PATHOLOGE, 2007, 28 (01): : 55 - 58